Organisation paid for research Program year 2024 Source: CMS Open Payments

Activmed Practice and Research Inc

Neither a doctor nor a teaching hospital

Research payments

$63,514

81 payments

Through program year 2024, Activmed Practice and Research Inc is reported as receiving $63,514 in research payments, across 81 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2024	Research	$12,999	19
2023	Research	$18,401	48
2022	Research	$32,114	14

Breakdown

Who paid Research payments · program years 2022–2024

AbbVie, Inc. $63,514 81 payments

Studies the money was for Research payments · program years 2022–2024

Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema) $44,230 39 payments
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS ) $11,004 5 payments
A multicenter, open Label study to assess the safety and efficacy of risankizumab for maintenance in moderate to severe plaque type psoriasis (LIMMITLESS) $7,956 36 payments
Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema) $325 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.